EMVision Medical Devices, situated in Queensland, has expanded its clinical advisory board to include three well-known experts in the field of stroke therapy. Professor Geoffrey…
Posts published by “Sarah Worrell”
Talking about her current projects, she is at present associated with several high-profile initiatives, including machine learning integrated biomarker research for cancer therapeutics. Additionally, her other significant work which has earned her recognition includes data visualization and complex data analytics, as well as academic research and scientific writing. Given her excellent grit for childcare, Sarah is one of the most regular writers for our latest category in the childcare section. As a student of pharmacy, Sarah already has a trail of reports published across various medical journals.
A new study suggests that staying fit and active into old age can help reduce the risk of dementia or Alzheimer’s. The study’s results say…
The US Food and Drug Administration (FDA) began considering how 3D Printing of medical devices at the point of care (PoC) would be regulated late…
Kaiser Permanente study assessed Pfizer BioNTech COVID-19 vaccine effectiveness against infection, hospitalization, and death up to 8 months after vaccination. A Kaiser Permanente study published…
The Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) has released its Health of Women Program Strategic Plan,…
Bill, a 31-year-old engineer from Ohio, has struggled with health anxiety for the most of his life. That’s why, in late 2020, he purchased a…
Loftware has acquired Prisym ID, a company that specialises in regulated content and label management solutions. According to a press release, Prisym ID focuses on…
The CDRH (Center for Devices and Radiological Health) of the US FDA (Food and Drug Administration) published draft advice on developing medical devices using PCLC…
MOWOOT’s CEO and co-founder, Dr. Markus Wilhelms, said: “The FDA’s Breakthrough Device Designation is an important milestone for our company since it confirms our opinion…